D-dimer testing: A narrative review
Advances in Clinical Chemistry · 2023 · 151-223
DOI: 10.1016/bs.acc.2023.02.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Clinical Chemistry, 2023. Verfasst von L Wauthier und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium. Hauptthemen laut MEDLINE: Venous Thromboembolism, COVID-19, Disseminated Intravascular Coagulation. Die Arbeit wurde bisher 48-mal zitiert (Crossref) und nennt 388 Literaturangaben.
Abstract (Originalsprache)
D-dimer containing species are soluble fibrin degradation products derived from plasmin-mediated degradation of cross-linked fibrin, i.e., 'D-dimer'. D-dimer can hence be considered a biomarker of in vivo activation of both coagulation and fibrinolysis, the leading clinical application in daily practice of which is ruling out venous thromboembolism (VTE). D-dimer has been further evaluated for assessing the risk of VTE recurrence and helping define optimal duration of anticoagulation treatment in VTE, for diagnosing disseminated intravascular coagulation (DIC), and for screening those at enhanced risk of VTE. D-dimer assays should however be performed as intended by regulatory agencies, as their use outside these indications might make them a laboratory-developed test (LDT). This narrative review is aimed at: (1) reviewing the definition of D-dimer, (2) discussing preanalytical variables affecting D-dimer measurement, (3) reviewing and comparing the assays performance and some postanalytical variables (e.g., different units and age-adjusted cutoffs), and (4) discussing the interest of D-dimer measurement across different clinical settings, including pregnancy, cancer, and coronavirus disease 2019 (COVID-19).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.
- Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium; Department of Pharmacy, Namur Research Institute for LIfe Sciences, University of Namur, Namur, Belgium.
- Université catholique de Louvain, CHU UCL Namur, Namur Thrombosis and Hemostasis Center, Hematology Laboratory, Yvoir, Belgium.
- Department of Pharmacy, Namur Thrombosis and Hemostasis Center, Namur Research Institute for Life Sciences, University of Namur, Belgium; QUALIblood s.a., Namur, Belgium.
- Department of Medicine, University of Ottawa, Ottawa, ON, Canada.
- Department of Emergency Medicine, CHU Angers; Institut MITOVASC, Equipe CARME, UMR CNRS 6015 - INSERM 1083, UNIV Angers; F-CRIN INNOVTE, Angers, France.
Zitieren
APA
Wauthier, L., Favresse, J., Hardy, M., Douxfils, J., Le Gal, G., Roy, P. M., van Es, N., Ay, C., Ten Cate, H., Lecompte, T., Lippi, G., & Mullier, F. (2023). D-dimer testing: A narrative review. Advances in Clinical Chemistry, 151-223. https://doi.org/10.1016/bs.acc.2023.02.006
Vancouver
Wauthier L, Favresse J, Hardy M, Douxfils J, Le Gal G, Roy PM, et al. D-dimer testing: A narrative review. Advances in Clinical Chemistry. 2023:151-223. doi:10.1016/bs.acc.2023.02.006
BibTeX
@article{Wauthier2023,
author = {Wauthier, L and Favresse, J and Hardy, M and Douxfils, J and Le Gal, G and Roy, P M and van Es, N and Ay, C and Ten Cate, H and Lecompte, T and Lippi, G and Mullier, F},
title = {D-dimer testing: A narrative review},
journal = {Advances in Clinical Chemistry},
year = {2023},
pages = {151--223},
doi = {10.1016/bs.acc.2023.02.006}
}
EUVIMED